InvestorPlace - Stock Market News, Stock Advice & Trading Tips
BBIO stock results show that BridgeBio Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
The post BBIO Stock Earnings: BridgeBio Pharma Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace